倍他乐克联合腔内隔绝术治疗主动脉夹层分离的有效性分析  

Analysis of the Efficacy of Betaloc Combined with Intracavitary Isolation in the Treatment of Aortic Dissection

作　　者：车丽玲[1] 何发明[1] CHE Li-ling;HE Fa-ming(Intensive Care Unit,Henan Provincial Thoracic Hospital,Zhengzhou Henan 450000,China)

机构地区：[1]河南省胸科医院重症临护室

出　　处：《药品评价》2019年第15期59-60,共2页Drug Evaluation

摘　　要：目的:分析倍他乐克联合腔内隔绝术治疗主动脉夹层分离的有效性。方法:选取2017年3月至2018年12月84例医院收治的主动脉夹层分离患者,随机将入选84例患者分为观察组(42例)与对照组(42例),对照组采用单纯腔内隔绝术治疗,观察组则采取倍他乐克联合腔内隔绝术治疗,观察两组患者的临床疗效和术后并发症发生率差异。结果:观察组患者的总治疗有效率明显高于对照组患者(P<0.05);两组患者术后并发症发生率比较差异无统计学意义。结论:倍他乐克联合腔内隔绝术治疗主动脉夹层分离具有较好的临床疗效,同时不会增加患者术后并发症发生率,可在临床推广使用。Objective: To analyze the efficacy of betaloc combined with intracavitary isolation in the treatment of aortic dissection. Methods: 84 patients with aortic dissection admitted to the hospital from March 2017 to December 2018 were selected and randomly selected into the observation group(42 cases) and the control group(42 cases). The control group was treated with simple intracavitary isolation, while the observation group was treated with betaloc combined with intracavitary isolation. The clinical efficacy and the incidence of postoperative complications of the two groups were observed. Results: The total effective rate of the observation group was significantly higher than that of the control group(P<0.05). There was no significant difference in the incidence of postoperative complications between the two groups(P>0.05). Conclusion: Bbetaloc combined with intracavitary isolation has good clinical efficacy in the treatment of aortic dissection, and will not increase the incidence of postoperative complications in patients, so it can be widely used in clinical practice.

关 键 词：倍他乐克 腔内隔绝术 主动脉夹层分离 

分 类 号：R654.3[医药卫生—外科学] R541.6[医药卫生—临床医学]